Development of a cell-based medicinal product: regulatory structures in the European Union

Author： Gálvez Patricia   Clares Beatriz   Hmadcha Abdelkrim   Ruiz Adolfina   Soria Bernat  

Publisher： Oxford University Press

ISSN： 1471-8391

Source： British Medical Bulletin, Vol.105, Iss.1, 2013-03, pp. : 85-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

European Regulatory Tools for Advanced Therapy Medicinal Products

By  

Transfusion Medicine and Hemotherapy, Vol. 40, Iss. 6, 2013-10 ,pp. : 409-412

Karger

Access to resources Recommend Favorite

Interview: Discussions on the development of human embryonic stem cell-based therapies

By Lebkowski Jane S  

Regenerative Medicine, Vol. 4, Iss. 5, 2009-09 ,pp. : 659-661

Future Medicine

Access to resources Recommend Favorite

Advanced Therapy Medicinal Products: How to Bring Cell-Based Medicinal Products Successfully to the Market - Report from the CAT-DGTI-GSCN Workshop at the DGTI Annual Meeting 2014

By  

Transfusion Medicine and Hemotherapy, Vol. 42, Iss. 3, 2015-04 ,pp. : 194-199

Karger

Access to resources Recommend Favorite

Dendritic Cell-Based Immunoregulatory Strategies

By  

International Archives of Allergy and Immunology, Vol. 127, Iss. 4, 2002-05 ,pp. : 251-258

Karger

Access to resources Recommend Favorite

A Cell-Based Multifactorial Approach to Angiogenesis

By  

Journal of Vascular Research, Vol. 42, Iss. 1, 2005-01 ,pp. : 29-37

Karger

Access to resources Recommend Favorite